BioNTech

18 Stories

Pfizer Asks FDA to Authorize COVID Vaccine for Young Kids

Decision expected between Halloween and Thanksgiving

(Newser) - Pfizer and BioNTech formally requested that the FDA authorize emergency use of a coronavirus vaccine for more than 28 million US children aged 5 to 11 on Thursday, keeping in line with a plan to have the doses available by Thanksgiving . The FDA will now gather its vaccines advisory committee...

Vaccine Name 'Comirnaty' Is Not Going Over Well
Vaccine Name 'Comirnaty'
Is Not Going Over Well
THE RUNDOWN

Vaccine Name 'Comirnaty' Is Not Going Over Well

Still planning to call it the 'Pfizer vaccine'? You're not alone

(Newser) - Pfizer's COVID-19 vaccine may have gotten full FDA approval Monday, but the reaction wasn't all good: Many were scratching their heads over the new name it will be marketed under, Comirnaty. "The person(s) who came up with this name should never be allowed to name anything ever...

Pfizer Vaccine Could Be Nearing 'Full Approval'

Latest data indicates 91.3% efficacy for 6 months

(Newser) - The coronavirus vaccine from Pfizer and BioNTech maintains 91.3% efficacy for at least six months after the second dose, even against the worrisome B.1.351 variant first identified in South Africa, the companies said Thursday. The findings—which double the previous best estimate of 90 days of protection,...

A Vaccine for Cancer? COVID Scientist Thinks So

Ozlem Tureci, founder of BioNTech, says shots to fight tumors could be in the offing

(Newser) - The scientist who won the race to deliver the first widely used coronavirus vaccine says people can rest assured the shots are safe, and the technology behind it will soon be used to fight another global scourge—cancer. Ozlem Tureci, who co-founded the German company BioNTech with her husband, Ugur...

2 Big Finds on the Pfizer Vaccine Front

One dose is effective, and the vaccine can be stored in ordinary freezers

(Newser) - A new study has produced two big finds that could have wide-ranging implications for coronavirus vaccine distribution and storage. Per the Wall Street Journal , the peer-reviewed research out of Israel published Thursday in the Lancet shows that just one shot of the Pfizer-BioNTech vaccine is 85% effective at stopping symptomatic...

Mixing Vaccines Could Provide 'Better Antibody Response'
New Study Looks
at Mixing Vaccines

New Study Looks at Mixing Vaccines

Human trial will attempt to replicate results found in mice

(Newser) - There have been limited cases of people receiving one coronavirus vaccine for their first dose, and a different vaccine for their second. So how will that affect their immunity? That's now the subject of a trial in the UK, seeking to discover whether a mix of vaccines proves effective...

US Philanthropists Getting Vaccine to Iran

Unidentified group aims to ship 150K doses of Pfizer vaccine to hard-hit country

(Newser) - An unidentified group of US-based philanthropists plans to send 150,000 doses of the Pfizer vaccine to Iran in the coming weeks, Iranian media reported Monday, per the AP . Details remained scarce in the report by the semiofficial Tasnim News Agency. It quoted the chief of the country's Red...

Pfizer Makes Big Vaccine Commitment

Pharma giant will give US another 100M doses by July 31

(Newser) - Pfizer and BioNTech will supply the US with an additional 100 million doses of the COVID-19 vaccine under a new agreement, reports the AP . The drugmakers said Wednesday that they expect to deliver all the doses by July 31. Pfizer already has a contract to supply the government with 100...

Vaccine Maker Tries to Ease Fears About New Strain

BioNTech CEO says its current vaccine should work against it, and will be fixable if it doesn't

(Newser) - Experiments will be needed to be sure, but BioNTech figures the vaccine the German company developed with Pfizer will work against the new coronavirus strain now racing through Britain. "We don't know at the moment if our vaccine is also able to provide protection against this new variant,...

This Long-Awaited Moment Arrives in US

First doses of COVID vaccine are administered

(Newser) - It's a big moment in the COVID fight: The first doses of a vaccine have been administered in the US. "I feel hopeful today. Relieved," ICU nurse Sandra Lindsay tells the AP after getting her shot at Long Island Jewish Medical Center in New York. She was...

90-Year-Old Grandmother Gets First UK Vaccine
UK Rolls Out Its Vaccine

UK Rolls Out Its Vaccine

90-year-old grandmother is the first recipient

(Newser) - Margaret Keenan turns 91 next week but already has her gift from the UK government. Keenan was the first person to receive a vaccine dose Tuesday as part of the UK's mass vaccination program , which will be rolling out 800,000 doses of Pfizer and BioNTech's vaccine at...

First Country Approves Pfizer Vaccine

UK to begin vaccinations 'within days'

(Newser) - British officials authorized a COVID-19 vaccine for emergency use on Wednesday, greenlighting the world's first shot against the virus that's backed by rigorous science and taking a major step toward eventually ending the pandemic. The go-ahead for the vaccine developed by Pfizer and BioNTech comes as the virus...

Final Analysis of Pfizer's Vaccine Trials Even Better

Final analysis of late-stage trials shows it's 95% effective, with no major safety worries

(Newser) - More good news from Pfizer and BioNTech, its German partner in the race to produce a coronavirus vaccine: They're expecting to seek an emergency use OK from the Food and Drug Administration "within days," per a statement cited by CNN . That's due to a final analysis...

'Dream Team' Couple Are Behind New Vaccine
'Dream Team' Couple Helped
Develop New Vaccine
THE RUNDOWN

'Dream Team' Couple Helped Develop New Vaccine

Huge challenges will await after approval

(Newser) - The exhilarating news that a COVID-19 vaccine was a big success in a large-scale trial is a victory for Pfizer—and for the husband-and-wife team behind BioNTech, the German biotech firm that collaborated with the American drugmaker. CEO Ugur Sahin and his wife, board member Oezlem Tuereci, founded the firm...

Pfizer's Update on Vaccine Is a 'Shift in Tone'

Announcement on application for emergency authorization predicts late November at the earliest

(Newser) - Last month, President Trump hinted that a COVID-19 vaccine could be available before Election Day, but the latest news from one of the leading developers seems to make that possibility even more remote. As the Wall Street Journal reports, Pfizer CEO Albert Bourla posted an open letter Friday announcing that,...

In Race for Vaccine, a Cold Truth
In Race for
Vaccine, a
Cold Truth

In Race for Vaccine, a Cold Truth

There may not be enough freezers icy enough to store the shots

(Newser) - "Do we have enough freezers?" That's a question many may not be pondering now, but it's an important one when it comes to a COVID-19 vaccine, per the Wall Street Journal . That's because the inoculation samples that may soon emerge might need to be stored at...

Operation Warp Speed Counts a Vaccine Win

Government will pay $1.95B for 100M doses, expected by year's end

(Newser) - The US has inked a deal that will have the country receiving the first 100 million doses of a coronavirus vaccine candidate in the works from Pfizer and German biotech firm BioNTech SE. The government could nab an additional 500 million doses under the agreement, which will see the US...

In Quest for COVID Vaccine, 107K 'Medical Heroes' Emerge

Volunteers coming out in droves to help 4 firms planning on starting phase 3 of clinical trials in fall

(Newser) - In early July, the National Institutes of Health launched a clinical trials network through which it hoped to enroll thousands of volunteers to test potential COVID-19 vaccines. Just a week or so later, more than 107,000 people had signed up. That's a number USA Today says will "...

18 Stories
Popular on Newser
We use cookies. By Clicking "OK" or any content on this site, you agree to allow cookies to be placed. Read more in our privacy policy.